These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24730531)

  • 41. Cangrelor: a review on pharmacology and clinical trial development.
    Franchi F; Rollini F; Muñiz-Lozano A; Cho JR; Angiolillo DJ
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1279-91. PubMed ID: 24138516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: facing a crossroad?
    Alexopoulos D
    Int J Cardiol; 2013 Jul; 167(1):292-3. PubMed ID: 23063138
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes.
    Holmes LE; Gupta R; Rajendran S; Luu J; French JK; Juergens CP
    Cardiovasc Ther; 2016 Oct; 34(5):330-6. PubMed ID: 27327862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
    Tantry US; Bonello L; Aradi D; Price MJ; Jeong YH; Angiolillo DJ; Stone GW; Curzen N; Geisler T; Ten Berg J; Kirtane A; Siller-Matula J; Mahla E; Becker RC; Bhatt DL; Waksman R; Rao SV; Alexopoulos D; Marcucci R; Reny JL; Trenk D; Sibbing D; Gurbel PA;
    J Am Coll Cardiol; 2013 Dec; 62(24):2261-73. PubMed ID: 24076493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selection of P2Y
    Tantry US; Navarese EP; Myat A; Gurbel PA
    Prog Cardiovasc Dis; 2018; 60(4-5):460-470. PubMed ID: 29339168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional testing methods for the antiplatelet effect of P2Y12 receptor antagonists.
    Price MJ; Barker CM
    Biomark Med; 2011 Feb; 5(1):43-51. PubMed ID: 21319964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P2Y
    Kupka D; Sibbing D
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):303-315. PubMed ID: 29338536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal DAPT duration: each in their own time.
    Hillegass WB; Brott BC
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):41-2. PubMed ID: 25521927
    [No Abstract]   [Full Text] [Related]  

  • 49. [Duration and Timing of Initiation of Therapy With Platelet P2Y12 Inhibitors in the Treatment of Patients With Acute Coronary Syndrome].
    SHalaev SV; Safiullina ZM
    Kardiologiia; 2018 Mar; (3):54-62. PubMed ID: 29782272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. G-protein-coupled receptors signaling pathways in new antiplatelet drug development.
    Gurbel PA; Kuliopulos A; Tantry US
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):500-12. PubMed ID: 25633316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination antiplatelet treatment in coronary artery disease patients: A necessary evil or an overzealous practice?
    Alexopoulos D; Katogiannis K; Sfantou D; Lekakis J
    Platelets; 2018 May; 29(3):228-237. PubMed ID: 29022423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. P2Y12 Receptor Antagonists and Morphine: A Dangerous Liaison?
    Giannopoulos G; Deftereos S; Kolokathis F; Xanthopoulou I; Lekakis J; Alexopoulos D
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27586412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry.
    Godschalk TC; Byrne RA; Adriaenssens T; Malik N; Feldman LJ; Guagliumi G; Alfonso F; Neumann FJ; Trenk D; Joner M; Schulz C; Steg PG; Goodall AH; Wojdyla R; Dudek D; Wykrzykowska JJ; Hlinomaz O; Zaman AG; Curzen N; Dens J; Sinnaeve P; Desmet W; Gershlick AH; Kastrati A; Massberg S; Ten Berg JM;
    JACC Cardiovasc Interv; 2017 Dec; 10(24):2548-2556. PubMed ID: 29268884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Looking beyond antiplatelet effect of P2Y12 inhibitors: is there anything to see?
    Sabbah M; Lønborg J; Engstrøm T; Nepper-Christensen L
    Int J Cardiol; 2020 Dec; 320():25. PubMed ID: 32652211
    [No Abstract]   [Full Text] [Related]  

  • 55. Potent P2Y12 receptor inhibitors in patients with acute coronary syndrome. Agents, indications, issues to consider in clinical practice.
    Sibbing D; Orban M; Massberg S
    Hamostaseologie; 2013; 33(1):9-15. PubMed ID: 23299202
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clopidogrel: interactions with the P2Y12 receptor and clinical relevance.
    Dorsam RT; Murugappan S; Ding Z; Kunapuli SP
    Hematology; 2003 Dec; 8(6):359-65. PubMed ID: 14668029
    [No Abstract]   [Full Text] [Related]  

  • 57. Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: post-hoc analysis of the randomized PRASFIT-ACS study.
    Nakamura M; Isshiki T; Kimura T; Ogawa H; Yokoi H; Nanto S; Takayama M; Kitagawa K; Ikeda Y; Saito S
    Int J Cardiol; 2015 Mar; 182():541-8. PubMed ID: 25679803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prasugrel hydrochloride for the treatment of acute coronary syndromes.
    Lhermusier T; Waksman R
    Expert Opin Pharmacother; 2015 Mar; 16(4):585-96. PubMed ID: 25633751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina.
    Bazemore TC; Nanna MG; Rao SV
    J Thromb Thrombolysis; 2017 Oct; 44(3):303-315. PubMed ID: 28730406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Response variability to P2Y12 receptor inhibitors: expectations and reality.
    Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.